HIV/AIDS Clinical Trials in Houston

Showing 121-140 of 238 trials

Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

NCT01492842

The proposed study is a substudy of ATN 106 and a cross sectional study intended to be conducted at each of the AMTUs newly participating in ATN III. The intent is to enroll all youth with behaviorally-acquired HIV who have enrolled in ATN 106. The study involves a review of the subjects' medical chart and a collection of an oral rinse sample.

HIV Infection

University of North Carolina, Chapel Hill272 participantsStarted Sep 2011

Aurora, Colorado, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +2 more locations

COMPLETED< 1 mile

Factors Affecting PrEP Adherence

NCT02411630

The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have sex with men (YMSM) who are taking PrEP as part of another study, either ATN 110 or ATN 113.

HIV Infection

University of North Carolina, Chapel Hill167 participantsStarted Jun 2013

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +9 more locations

Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

Factors Affecting PrEP Adherence

HIV/AIDS Trials in Other Cities

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Treatment of Chronic Cryptosporidiosis in AIDS Patients

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

C2P Mobilization Intervention (Pilot)

HIV Treatment-Readiness Measure (HTRM) Validation

Treatment De-Intensification and Residual HIV-1 in Youth

CDC-ATN Linkage Evaluation

Immunologic Memory (Supp. of ATN 024)

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Linkage to Care - Part II

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

Other Conditions in Houston